Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 103

Sort by

Sort Order Select

Journal Articles

FLT3 Inhibitor Correlative Laboratory Assays Impact Outcomes in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia (ALL) Patients Treated with Lestaurtinib: AALL0631, a Children's Oncology Group Study

Patrick A. Brown, MD, John Kairalla, Joanne M. Hilden, MD, Zoann Eckert Dreyer, MD, Andrew J. Carroll, PhD, Nyla A. Heerema, PhD, Cindy Wang, MS, Meenakshi Devidas, PhD, William L. Carroll, MD, Elizabeth A. Raetz, MD, Mignon L. Loh, MD, Stephen P. Hunger, MD, Michael J. Borowitz, MD PhD, Donald Small, MD PhD

Blood (2019) 134 (Supplement_1): 1293.

https://doi.org/10.1182/blood-2019-130564

Published: 2019

Journal Articles

Mechanism Underlying a Role for Factor XIII (FXIII) Polymorphism in Sickle Cell Disease-Associated Priapism

Marilyn J. Telen, MD, Milena Batchvarova, MS, Joan D Beckman, MD PhD, Martha Delahunty, PhD, Karen L Soldano, BS, Allison E Ashley-Koch, PhD, Alisa S. Wolberg, PhD

Blood (2018) 132 (Supplement 1): 2361.

https://doi.org/10.1182/blood-2018-99-116946

Published: 2018

Journal Articles

Erythrocyte Cytochrome b Reductase 1 Protein Levels and Structure in Sickle Cell Patients

Richard Kulmacz, PhD, Hamidreza Farzaneh, MS, Kathryn L McElhinney, BS, Jose M. Rodriguez, BS, Nicole C. Thomason, BS, Ehsan Irajizad, BE, Vladimir Berka, PhD, Wen Liu, PhD, Modupe Idowu, MD, Harinder S. Juneja, MD

Blood (2018) 132 (Supplement 1): 3654.

https://doi.org/10.1182/blood-2018-99-119885

Published: 2018

Journal Articles

A High-Throughput Screening Approach to Identify Therapeutics for the Treatment of Diamond-Blackfan Anaemia

Lorena Nunez Villacis, Sheren J Al-Obaidi, Piyush Madhamshettiwar, PhD, Nadine Hein, PhD, Jun Chen, MD PhD, Priscilla Soo, Perlita Poh, Megan Pavy, Kaylene J Simpson, PhD, Thomas John Gonda, PhD BSc, Richard B Pearson, PhD, Johan Flygare, MD PhD, Katherine M Hannan, PhD, Amee J George, PhD, Ross Hannan, PhD

Blood (2018) 132 (Supplement 1): 3859.

https://doi.org/10.1182/blood-2018-99-114303

Published: 2018

Journal Articles

CLL Cells with 13q- Are Characterized By High BCL2 Levels and CLL Cells with Trisomy-12 By Increased Activation of STAT3 and NF-κB

Uri Rozovski, David M. Harris, Ping Li, PhD, Zhiming Liu, Preetesh Jain, MBBS, MDDM, PhD, Alessandra Ferrajoli, MD, Jan A. Burger, MD PhD, Prithviraj Bose, MD, Philip A. Thompson, MBBS, Nitin Jain, MD, William G. Wierda, MD PhD, Michael J. Keating, MD, Zeev E. Estrov, MD

Blood (2018) 132 (Supplement 1): 4411.

https://doi.org/10.1182/blood-2018-99-114909

Published: 2018

Journal Articles

A Novel Mechanism of Factor VIIa/Tissue Factor (TF)-Catalyzed Activation and Inactivation of B-Domain-Deleted Factor VIII in the Early Initiation Phases of Coagulation

Yuto Nakajima, MD, Koji Yada, MD PhD, Keiji Nogami, MDPhD, Midori Shima, MD PhD

Blood (2018) 132 (Supplement 1): 1162.

https://doi.org/10.1182/blood-2018-99-115645

Published: 2018

Journal Articles

Long Acting Zoledronic Acid Treatment for Vertebral Fracture Prevention in Multipl Myeloma Patients with Osteoporosis

Murat Cinarsoy, Ahmet Kursad Gunes, Hilmi Erdem Gozden

Blood (2018) 132 (Supplement 1): 1954.

https://doi.org/10.1182/blood-2018-99-111133

Published: 2018

Journal Articles

Phosphatidylserine-Exposing Extracellular Vesicles after Splenectomy Are Associated with Increased D-Dimers and Fibrin Generation in Hereditary Hemolytic Anemia

Stephanie Van Straaten, MD, Chi Hau, Najat Hajji, Jill Verhoeven, Roger Schutgens, MD PhD MSc, Wouter van Solinge, PhD, Richard van Wijk, PhD, Rienk Nieuwland, PhD, Eduard J. van Beers, MD PhD

Blood (2018) 132 (Supplement 1): 630.

https://doi.org/10.1182/blood-2018-99-110918

Published: 2018

Journal Articles

Quantitative Analysis of Von Willebrand Factor (VWF) Multimers in Von Willebrand Disease (VWD) Patients Recruited through the Zimmerman Program for the Molecular and Clinical Biology of VWD

Sandra L Haberichter, PhD, Pamela A Christopherson, Veronica H Flood, MD, Joan Cox Gill, MD, Kenneth Dale Friedman, MD, Robert R. Montgomery, MD

Blood (2017) 130 (Supplement 1): 1085.

https://doi.org/10.1182/blood.V130.Suppl_1.1085.1085

Published: 2017

Journal Articles

Tafazzin (TAZ) Regulates the Differentiation of AML Cells By Reducing Levels of the Phospholipid Phosphatidylethanolamine

Blood (2017) 130 (Supplement 1): 788.

https://doi.org/10.1182/blood.V130.Suppl_1.788.788

Published: 2017

Journal Articles

Human Reticulocytes Express More RUVBL1 Than Mature Human Erythrocytes

Beverly W Baron, Joseph M. Baron, MD

Blood (2017) 130 (Supplement 1): 4745.

https://doi.org/10.1182/blood.V130.Suppl_1.4745.4745

Published: 2017

Journal Articles

Daratumumab Mitigates B-Cell Receptor Signaling and Enhances Antitumor Activity of Ibrutinib in Chronic Lymphocytic Leukemia (CLL) Cells

Alak Manna, PhD, Sharoon Akhtar, MPhil, Zahara Meghji, Kirtipal Bhatia, Paul Yi, BS, Sameer A. Parikh, MD, Wei Ding, MD PhD, Jose F. Leis, MD PhD, Taimur Sher, MD, Fabio Malavasi, MD, Victoria R. Alegria, Sikander Ailawadhi, Asher A. Chanan-Khan, MD, Aneel Paulus, MD

Blood (2017) 130 (Supplement 1): 3019.

https://doi.org/10.1182/blood.V130.Suppl_1.3019.3019

Published: 2017

Journal Articles

Myeloma Lytic Bone Lesions Characterization with WB-LDCT and 18 f-FDG PET/MRI

Albana Lico, MD, Gregorio Barilà, MD, Filippo Crimì, MD, Lucia Checuz, MD, Tamara Berno, MD, Stefania Vio, MD, Antonio Branca, MD, Lucia Ammirati, MD, Matteo Leoncin, MD, Pietro Zucchetta, MD, Carmelo Lacognata, MD, Francesco Piazza, MD, Gianpietro Semenzato, MD, Renato Zambello, MD

Blood (2017) 130 (Supplement 1): 1788.

https://doi.org/10.1182/blood.V130.Suppl_1.1788.1788

Published: 2017

Journal Articles

Ruxolitinib Induces Changes in Histone Modification Status in Patients Entered into the Majic Clinical Trial

Suzanne McPherson, MB Bch BAO MRCPUK FRCPath Part 1, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Adam J Mead, MD PhD, Ken I Mills, BSc PhDFRCPath, Mary Frances McMullin, MB,Bch BAO, MD FRCPath

Blood (2017) 130 (Supplement 1): 5285.

https://doi.org/10.1182/blood.V130.Suppl_1.5285.5285

Published: 2017

Journal Articles

A Low Concentration of ABL001 Potentiates In Vitro TKI-Induced Bcr-Abl Kinase Inhibition in CML Cells

Verity A Saunders, BSc (Hons), Jueqiong Wang, PhD, Liu Lu, PhD, Laura N Eadie, PhD, Jennifer A McLean, Jarrad M Goyne, BMedSc (Hons), David T. Yeung, BSc, MBBS, FRACP, FRCPA, Deborah L White, PhD FFSc (RCPA), Timothy P Hughes, MD FRACP, FRCPA, MBBS

Blood (2016) 128 (22): 1121.

https://doi.org/10.1182/blood.V128.22.1121.1121

Published: 2016

Journal Articles

Abnormal Heavy/Light Chain Ratio after Treatment Is a Robust Predictor of Shorter Survival in Patients with IgA Myeloma

Yoshiaki Abe, MD, Yasuhito Suehara, MD, Hiroyuki Takamatsu, MD PhD, Yoshiaki Usui, MD, Kentaro Narita, MD, Masami Takeuchi, MD, Kelly Endean, PhD, Kosei Matsue, MD PhD

Blood (2016) 128 (22): 3254.

https://doi.org/10.1182/blood.V128.22.3254.3254

Published: 2016

Journal Articles

Co-Administration of Factor XIII with Hemostatic Agents in Hemophilia Promotes Clot Stability and Composition

Joan D. Beckman, MDPhD, Lori A. Holle, PhD, Alisa S. Wolberg, PhD

Blood (2016) 128 (22): 2589.

https://doi.org/10.1182/blood.V128.22.2589.2589

Published: 2016

Journal Articles

Novel Human Factor VIII Variant with Impaired Intracellular Processing Exhibits Enhanced In Vivo Efficacy

Giang N. Nguyen, B.S., Christian M. Wood, Tanner Dirstine, B.S., Robert J. Davidson, B.S., Denise E. Sabatino, PhD

Blood (2016) 128 (22): 256.

https://doi.org/10.1182/blood.V128.22.256.256

Published: 2016

Journal Articles

In Chronic Lymphocytic Leukemia ΔCT7544-7545 Mutant NOTCH1 Maintains Transcription Factor Activity with Longer Lasting Effects Due to Slower Degradation

Jennifer Edelmann, MD, Tetyana Klymenko, PhD, Chen Lu, PhD, Emma Vilventhraraja, Sven Estenfelder, Eugen Tausch, Stephen A Beers, PhD, Stephan Stilgenbauer, Mark S Cragg, PhD, Andrejs Ivanov, PhD, John Gribben

Blood (2016) 128 (22): 971.

https://doi.org/10.1182/blood.V128.22.971.971

Published: 2016

Journal Articles

Panobinostat-Augmented Cytarabine and Daunorubicin (7+3) Induction for Older Patients with AML or High-Risk MDS Is Well Tolerated and Results in Favorable Clinical Outcomes: The Panda Trial

Matthew J. Wieduwilt, MD PhD, Scott Thomas, PhD, Rebecca L. Olin, MD MSCE, Aaron C. Logan, MDPhD, Lloyd E. Damon, MD, Thomas G. Martin, III, MD, McNancy Kang, Peter H. Sayre, MD PhD, Wanda Boyer, NP,MSN, Karin ML Gaensler, MD, Kirsten Anderson, Pamela Munster, MD, Charalambos Andreadis, MD MSCE

Blood (2015) 126 (23): 1337.

https://doi.org/10.1182/blood.V126.23.1337.1337

Published: 2015

NARROW

FLT3 Inhibitor Correlative Laboratory Assays Impact Outcomes in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia (ALL) Patients Treated with Lestaurtinib: AALL0631, a Children's Oncology Group Study

Mechanism Underlying a Role for Factor XIII (FXIII) Polymorphism in Sickle Cell Disease-Associated Priapism

Erythrocyte Cytochrome b Reductase 1 Protein Levels and Structure in Sickle Cell Patients

A High-Throughput Screening Approach to Identify Therapeutics for the Treatment of Diamond-Blackfan Anaemia

CLL Cells with 13q- Are Characterized By High BCL2 Levels and CLL Cells with Trisomy-12 By Increased Activation of STAT3 and NF-κB

A Novel Mechanism of Factor VIIa/Tissue Factor (TF)-Catalyzed Activation and Inactivation of B-Domain-Deleted Factor VIII in the Early Initiation Phases of Coagulation

Long Acting Zoledronic Acid Treatment for Vertebral Fracture Prevention in Multipl Myeloma Patients with Osteoporosis

Phosphatidylserine-Exposing Extracellular Vesicles after Splenectomy Are Associated with Increased D-Dimers and Fibrin Generation in Hereditary Hemolytic Anemia

Quantitative Analysis of Von Willebrand Factor (VWF) Multimers in Von Willebrand Disease (VWD) Patients Recruited through the Zimmerman Program for the Molecular and Clinical Biology of VWD

Tafazzin (TAZ) Regulates the Differentiation of AML Cells By Reducing Levels of the Phospholipid Phosphatidylethanolamine

Human Reticulocytes Express More RUVBL1 Than Mature Human Erythrocytes

Daratumumab Mitigates B-Cell Receptor Signaling and Enhances Antitumor Activity of Ibrutinib in Chronic Lymphocytic Leukemia (CLL) Cells

Myeloma Lytic Bone Lesions Characterization with WB-LDCT and 18 f-FDG PET/MRI

Ruxolitinib Induces Changes in Histone Modification Status in Patients Entered into the Majic Clinical Trial

A Low Concentration of ABL001 Potentiates In Vitro TKI-Induced Bcr-Abl Kinase Inhibition in CML Cells

Abnormal Heavy/Light Chain Ratio after Treatment Is a Robust Predictor of Shorter Survival in Patients with IgA Myeloma

Co-Administration of Factor XIII with Hemostatic Agents in Hemophilia Promotes Clot Stability and Composition

Novel Human Factor VIII Variant with Impaired Intracellular Processing Exhibits Enhanced In Vivo Efficacy

In Chronic Lymphocytic Leukemia ΔCT7544-7545 Mutant NOTCH1 Maintains Transcription Factor Activity with Longer Lasting Effects Due to Slower Degradation

Panobinostat-Augmented Cytarabine and Daunorubicin (7+3) Induction for Older Patients with AML or High-Risk MDS Is Well Tolerated and Results in Favorable Clinical Outcomes: The Panda Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only